<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="140">
  <stage>Registered</stage>
  <submitdate>5/08/2005</submitdate>
  <approvaldate>9/08/2005</approvaldate>
  <actrnumber>ACTRN12605000116628</actrnumber>
  <trial_identification>
    <studytitle>The effect of progressive resistance training on knee articular cartilage morphology in osteoarthritic patients</studytitle>
    <scientifictitle>The effect of 6 month high intensity progressive resistance training on knee articular cartilage morphology in female osteoarthritic patients</scientifictitle>
    <utrn />
    <trialacronym>REACH</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects will be randomised into a progressive resistance training (PRT) or sham-exercise group. The PRT group will train at 80% of their peak strength, using Keiser pneumatic resistance machines, and progress approximately 3% per session. Strength will be re-assessed fortnightly. Exercises will target muscles around the hip and knee. The sham-exercise group will train on the same equipment as the PRT group except hip adduction, but without added resistance or progression. Both groups will train 3 days per week for roughly 45 minutes for 6 months.</interventions>
    <comparator>Sham-exercise group.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Articular cartilage morphology following 6 months high intensity progressive resistance training.</outcome>
      <timepoint>Following 6 months high intensity progressive resistance training.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Muscle and fat cross-sectional area (CSA)</outcome>
      <timepoint>Pre and post</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Muscle strength, power, endurance, and contraction velocity</outcome>
      <timepoint>Pre, 3 months, &amp; post</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Medications</outcome>
      <timepoint>Pre, 3 months, &amp; post</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Body composition</outcome>
      <timepoint>Pre, 3 months, &amp; post</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Balance; Physical function</outcome>
      <timepoint>Pre, 3 months, &amp; post</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Questionnaires 
-Habitual exercise (PASE) -WOMAC index (pain, stiffness and functional ability)
-Depressive symptoms (Depression Scale) -Quality of life (SF36)
-Confidence performing physical activity (Ewart) -Demographics</outcome>
      <timepoint>Pre, 3 months, &amp; post</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Primary Osteoarthritis in at least one knee using standard criteria of the American College of Rheumatology (ACR) criteria for classification of clinical osteoarthritis -Ambulatory without human assistance-Willingness to be randomised to experiential or control group-Ability to attend scheduled exercise and testing sessions</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Regular exercise of any kind over the past 3 months (&gt;1dpw). -Secondary osteoarthritis (traumatic or post-surgical), rheumatic disease, gouty or septic arthritis, Paget's disease, pseudogout, major congenital abnormalities, hemochromatosis, Wilson's disease and other rare forms of arthritis -Joint injury, injection or surgery within the past 6 months or knee joint replacement.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomisation of subjects will be carried out using opaque envelopes with their exercise group assignment inside. The label in the envelope will only state Group A or Group B. Researchers will not disclose to subjects which group is hypothesized to be the preferential group.</concealment>
    <sequence>Using randomisation software from www.randomization.com. Subjects will be stratified according to WOMAC scores (cut-off WOMAC difficulty score of 53) and whether or not they are currently taking and/or have taken (last 6 months) either glucosamine or chondroitin at any dosage (yes/no)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>2/04/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney, Faculty of Health Sciences, School of Exercise and Sport Science</primarysponsorname>
    <primarysponsoraddress>Faculty of Health Science University of Sydney PO Box 170 Lidcombe NSW 1825</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Cumberland Grant Category B. University of Sydney</fundingname>
      <fundingaddress>Faculty of Health Science University of Sydney PO Box 170 Lidcombe NSW 1825</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Sydney R &amp; D Grant (S4201 U3301)</fundingname>
      <fundingaddress>Faculty of Health Science University of Sydney PO Box 170 Lidcombe NSW 1825</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>no</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite>http://www2.fhs.usyd.edu.au/ess/vanwanseele/reach.htm</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Sydney Human Research Ethics Committee.</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Prince of Wales Medical Research Institute</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Benedicte Vanwanseele</name>
      <address>School of Exercise and Sport Science
Faculty of Health Science
University of Sydney
PO Box 170
Lidcombe NSW 1825</address>
      <phone>+61 2 93519328</phone>
      <fax>+61 2 93519204</fax>
      <email>b.vanwanseele@usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms. Angela Lange</name>
      <address>School of Exercise and Sport Science
Faculty of Health Science
University of Sydney
PO Box 170
Lidcombe NSW 1825</address>
      <phone>+61 2 93519279</phone>
      <fax>+61 2 93519204</fax>
      <email>alan5625@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms. Angela Lange</name>
      <address>School of Exercise and Sport Science Faculty of Health Science University of Sydney PO Box 170 Lidcombe NSW 1825</address>
      <phone>+61 2 93519279</phone>
      <fax>+61 2 93519204</fax>
      <email>alan5625@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>